Identification and validation of FGFR2 peptide for detection of early Barrett's neoplasia.

Zhou, Juan; He, Lei; Pang, Zhijun; Appelman, Henry D; Kuick, Rork; Beer, David G; Li, Meng; Wang, Thomas D

Zhou, Juan; He, Lei; Pang, Zhijun; Appelman, Henry D; Kuick, Rork; Beer, David G; Li, Meng; Wang, Thomas D.

Afiliación

Zhou J; Department of Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan 48109, USA.
He L; Biotechnology Center, School of Pharmacy, The Fourth Military Medical University, Xi'an 710032, China.
Pang Z; Biotechnology Center, School of Pharmacy, The Fourth Military Medical University, Xi'an 710032, China.
Appelman HD; Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA.
Kuick R; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan 48109, USA.
Beer DG; Department of Surgery, Section of Thoracic Surgery, University of Michigan, Ann Arbor, Michigan 48109, USA.
Li M; Biotechnology Center, School of Pharmacy, The Fourth Military Medical University, Xi'an 710032, China.
Wang TD; Department of Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan 48109, USA.

Oncotarget ; 8(50): 87095-87106, 2017 Oct 20.

Article en En | MEDLINE | ID: mdl-29152066

Palabras clave

FGFR2; cancer; esophagus; peptide

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google